Herpes Labialis (Oral Herpes) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 28 pages | ID: H208AD39986EN
VPAResearch

Abstracts

Herpes Labialis (Oral Herpes) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Herpes Labialis (Oral Herpes) disease clinical trials. The research work analyzes the ongoing Herpes Labialis (Oral Herpes) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Herpes Labialis (Oral Herpes) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Herpes Labialis (Oral Herpes) clinical trials.

Scope of the Report-

• Ongoing Herpes Labialis (Oral Herpes) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Herpes Labialis (Oral Herpes)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Herpes Labialis (Oral Herpes) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Herpes Labialis (Oral Herpes) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Herpes Labialis (Oral Herpes) Trials by Phase
3.2 Ongoing Herpes Labialis (Oral Herpes) Trials by Type
3.3 Ongoing Herpes Labialis (Oral Herpes) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Herpes Labialis (Oral Herpes) Trials
4.2 Top 10 Countries conducting Herpes Labialis (Oral Herpes) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Herpes Labialis (Oral Herpes) Trials by Sponsor Type
5.2 Herpes Labialis (Oral Herpes) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Herpes Labialis (Oral Herpes) Trials by year
6.2 Subjects Recruited for Herpes Labialis (Oral Herpes) Trials by Phase
6.3 Subjects Recruited for Herpes Labialis (Oral Herpes) Trials by Trial Type
6.4 Subjects Recruited for Herpes Labialis (Oral Herpes) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Herpes Labialis (Oral Herpes) Trials- Phase
7.2 Ongoing Herpes Labialis (Oral Herpes) Trials- Phase
7.3 Ongoing Herpes Labialis (Oral Herpes) Trials- Phase
7.4 Ongoing Herpes Labialis (Oral Herpes) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Herpes Labialis (Oral Herpes)- Clinical Trials by Country
Figure 2: Herpes Labialis (Oral Herpes)- Clinical Trials by Phase of Development, 2018
Figure 3: Herpes Labialis (Oral Herpes)- Clinical Trials by Status, 2018
Figure 4: Herpes Labialis (Oral Herpes)- Clinical Trials by Type, 2018
Figure 5: Herpes Labialis (Oral Herpes)- Clinical Trials Split by Region, 2000-2018
Figure 6: Herpes Labialis (Oral Herpes)- Clinical Trials by Type of Economy, 2018
Figure 7: Herpes Labialis (Oral Herpes)- Enrolment by Phase, 2018
Figure 8: Herpes Labialis (Oral Herpes)- Enrolment by Trial Type, 2018
Figure 9: Herpes Labialis (Oral Herpes)- Enrolment by Recruitment Status, 2018
Figure 10: Herpes Labialis (Oral Herpes)- Clinical Trials by Sponsor Type, 2018
Figure 11: Herpes Labialis (Oral Herpes)- Enrolment by Type of Sponsors
Figure 12: Herpes Labialis (Oral Herpes)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Herpes Labialis (Oral Herpes)- Clinical Trials by Sponsor Type, 2018
Table 2: Herpes Labialis (Oral Herpes)- Clinical Trials by Economy Type, 2018
Table 3: Herpes Labialis (Oral Herpes)- Clinical Trials by Region, 2018
Table 4: Herpes Labialis (Oral Herpes)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Herpes Labialis (Oral Herpes)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Herpes Labialis (Oral Herpes)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Herpes Labialis (Oral Herpes)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Herpes Labialis (Oral Herpes)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Herpes Labialis (Oral Herpes)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company